Practice-Changing Medicine

Innovative Strategy Drives Success in Refractory AML

A patient with KMT2A-rearranged AML achieved deep remission through menin inhibition before and after a high-risk third allogeneic transplant.

Complex Case Spotlight

Coordinating Breast Cancer Care for a Patient in Early Pregnancy

The patient delivered safely at 39 weeks, with surgery occurring at end of the first trimester and chemotherapy initiated in the second.

Practice-Changing Medicine

‘Freezing Away’ Advanced Lung Cancer

First-in-human phase 1 trial evaluating bronchoscopic cryoimmunotherapy in advanced NSCLC shows promising results.

Advancing Science

Oral Microbiome Signatures Associated with Elevated Pancreatic Cancer Risk

JAMA Oncology study links 27 species of oral microbes to a nearly 3.5 times greater risk of developing pancreatic cancer.

Expert Perspectives

Efficacy Without Excess Is Reshaping Breast Cancer Trials

Clinical trialist Dr. Douglas Marks discusses NYU Langone’s extensive breast cancer trial portfolio and approaches to lowering treatment toxicity. 

Expert Perspectives

Putting Translational Oncology to Work

Dr. Manuel Hidalgo, renowned translational researcher and co-director of the new GI Cancer Center, reflects on his career advancing anticancer agents and his vision for the center.
Load More